COVER STORY
IV catheter innovation improves care quality CSJ
Good catheter design can significantly reduce risks and complications, while ensuring compliance with national guidelines.
The likelihood of being admitted to hospital and needing an Intra-Venous (IV) Peripheral Cannula is estimated between 60% to 90%1 for patients. Therefore, most of us, if needing hospital treatment, may have a peripheral cannula inserted. But, as clinicians are aware, there are risks associated with IV cannulae. The procedure, while seemingly straightforward, carries the potential for complications, including catheter-related blood stream infection (CRBSI), phlebitis, extravasation, infiltration, haematoma and occlusion.
BD considers all angles of patient safety at
every stage of the cannulation procedure, from insertion to removal and everything in- between, through the breadth of products offered and our associates’ expert support of the vascular access healthcare professional. BD Vascular Access Management is an integrated approach to vascular access device (VAD) selection, site preparation, placement, care and maintenance built around evidence based practice.
Good catheter design can significantly reduce risks and complications: ports of ported-peripheral cannula, for example, have been identified as potential entry points for microorganisms,2
of national guidance, aimed at improving care quality. EPIC33
recommend the use of polyurethane or fluorinated polymer catheters and both EPIC3 and Royal College of Nursing4
prompting the development (2014) guidelines
(2016)
state that it is essential to use a catheter with the minimum required ports or lumens essential for management of the patient. CRBSI is not the only concern, however.
A market survey revealed that gaining vascular access, conducting a successful cannulation, and preventing infection were among clinicians’ top concerns.6 Understandably so – indeed, which other industry would accept such a failure rate? To help acute care hospitals comply with
Rates of intravenous peripheral cannula insertion failure and unscheduled restarts remain unacceptably high, ranging from 33% to 69%.5
6 I
WWW.CLINICALSERVICESJOURNAL.COM
the latest guidance, improve clinicians’ confidence, and enhance safety – for both patients and staff – BD has recently launched an innovative range of non-ported, passive safety IV peripheral cannulas: BD Cathena™, suitable for adult patients and Neoflon Pro Safety™, designed specifically to reduce the risk of complications in vulnerable neonatal and paediatric patients. Vascular access can prove particularly challenging in some patient groups – such as the elderly, young children and neonates – which can be stressful for both the patient and the clinician. In addition, with few options on the market for neonatal and paediatric patients featuring safety mechanisms, clinicians have previously relied on non-safety peripheral cannula that are less than optimal and increase the risk of injury to healthcare staff.
Improved peripheral cannula design can tackle these concerns by facilitating optimal technique, reducing repeated attempts at cannulation, and minimising the potential ingress of pathogens.
Reasons to make a change
Hospitals across the UK and Ireland are choosing the BD portfolio of non-ported devices in a bid to reduce infection rates and comply with best practice guidelines. To help clinicians better understand how catheter
THE CLINICAL SERVICES JOURNAL WWW. CLINICALSER VICESJOURNAL .COM
VOLUME 18 l ISSUE 8 l SEPTEMBER 2019
Gettingtotheheart ofano-deal Brexit The mechanicsof
cleaning instruments
Protecting key areas against HCAIs
design can make a difference, BD provides below the answers to some commonly asked questions:
How can BD Cathena increase clinician’s confidence during cannulation and improve technique?
BD Cathena safety IV peripheral cannulae incorporate a triple flash confirmation system for accuracy and control, which can reduce the chance of a painful missed insertion. The BD Instaflash™ notched needle technology, visible in the cannula, provides the first and immediate confirmation of vein entry. Secondary confirmation occurs when blood appears in the flash chamber after lowering and advancing the cannula, re-assuring the clinician that the cannula is still in the vein. The third flashback occurs when blood flows into the coloured cannula hub as the needle is removed, providing another point of confirmation. This is particularly beneficial during challenging insertions and increases the confidence of the practitioner. BD Cathena is designed ergonomically to work with the clinician’s natural movement and insertion technique. Supplied with or without wings, to meet the clinician’s preference grip, the device features a primary tab and secondary anti-rotation tab, which provides tactile engagement during insertion. By providing a clear confirmation of successful insertion and potential to improve first stick success, BD Cathena can reduce complications associated with skin and vein damage, caused by repeated insertion attempts, while preventing delays in medication or therapy delivery.
SEPTEMBER 2019
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92
